Clinical Trials in Minneapolis

Showing 11941-11960 of 14,456 trials

Training Effects on Skeletal Muscle Fatty Acid Metabolism

NCT00786487

We are interested in how skeletal muscle processes fat and how this may affect insulin resistance. This is an important question since insulin resistance predates and predicts type 2 diabetes. We know that if pharmaceutical grade fat is infused into people, they develop insulin resistance. Likewise, we would like to infuse pharmaceutical grade fat into trained subjects, believing that trained subjects will have less insulin resistance, less decline in muscle energy function, and less accumulation of fat metabolites than untrained subjects. For comparing the effects of the pharmaceutical grade fat infusion, we will also have a group of trained and untrained subjects given a control (glycerol) infusion. Glycerol is basically the same as pharmaceutical grade fat infusion without the fat component.

Healthy Volunteers

University of Minnesota33 participantsStarted Jan 2009

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

NCT00206908

This project is designed to evaluate the clinical utility of a novel blood test, the Triage Stroke Panel, as an aid in the diagnosis and assessment of stroke. The Triage Stroke Panel test device, used with the Triage MeterPlus, is a rapid, point-of-care immunoassay. The test measures the concentration of various analytes present in EDTA-anticoagulated whole blood or plasma, specifically B-type natriuretic peptide (BNP), fibrin degradation products containing D-Dimer, matrix metalloproteiase-9 (MMP-9), and S-100B. The test utilizes a proprietary algorithm for the automatic calculation of a single Multimarker Index (MMX) result from the individual biomarker values. The MMX result is being evaluated for use as an aid in the assessment and diagnosis of stroke.

StrokeStroke Mimic(Conditions Presenting With Stroke-like Conditions)

Abbott RDx Cardiometabolic900 participantsStarted Jul 2002

Birmingham, Alabama, United States • Los Angeles, California, United States • Denver, Colorado, United States +19 more locations

Training Effects on Skeletal Muscle Fatty Acid Metabolism

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Find Trials by Condition in Minneapolis

Rollover Study of VX-770 in Cystic Fibrosis Subjects

Tivantinib in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Safety and Efficacy of Merlin (Ethanol and Glycolic Acid Mixture) for the Treatment of Cold Sores

Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

Electrothermal Arthroscopic Capsulorrhaphy (ETAC) and Open Inferior Capsular Shift in Patients With Shoulder Instability

Screening for Occult Malignancy in Patients With Idiopathic Venous Thromboembolism

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)

Open-label Study of Levetiracetam Intravenous Infusion in Children (1 Month-4 Years Old) With Epilepsy

Evaluation of Meningococcal C Vaccine Programmes in Canadian Children